UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response

Journal of controlled release, 2010-07, Vol.145 (2), p.102-108

2010

Volltextzugriff (PDF)

Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems

Scientific reports, 2022-07, Vol.12 (1), p.12448-12448, Article 12448

2022

Volltextzugriff (PDF)

Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses

Journal of controlled release, 2012-02, Vol.158 (1), p.72-77

2012

Volltextzugriff (PDF)

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses

Biochimica et biophysica acta, 2005-12, Vol.1718 (1), p.22-31

2005

Volltextzugriff (PDF)

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation

European journal of pharmaceutical sciences, 2018-10, Vol.123, p.268-276

2018

Volltextzugriff (PDF)

Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses

PloS one, 2012-03, Vol.7 (3), p.e34255-e34255

2012

Volltextzugriff (PDF)

The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production

Journal of controlled release, 2011-09, Vol.154 (2), p.131-137

2011

Volltextzugriff (PDF)

Developing solid particulate vaccine adjuvants: surface bound antigen favours a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity

Current drug delivery, 2013-06, Vol.10 (3), p.268-278

2013

Volltextzugriff (PDF)

The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: The immunological consequences of the biodistribution profile

Journal of controlled release, 2016-10, Vol.239, p.107-117

2016

Volltextzugriff (PDF)

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency

Journal of controlled release, 2022-02, Vol.342, p.388-399

2022

Volltextzugriff (PDF)

Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems

Journal of controlled release, 2010-11, Vol.147 (3), p.342-349

2010

Volltextzugriff (PDF)

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen

Journal of controlled release, 2010-03, Vol.142 (2), p.180-186

2010

Volltextzugriff (PDF)

Effect of Incorporating Cholesterol into DDA:TDB Liposomal Adjuvants on Bilayer Properties, Biodistribution, and Immune Responses

Molecular pharmaceutics, 2014-01, Vol.11 (1), p.197-207

2014

Volltextzugriff (PDF)

Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants

Journal of pharmacy and pharmacology, 2014-03, Vol.66 (3), p.358-366

2014

Volltextzugriff (PDF)

Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirus

Nanomedicine, 2022-02, Vol.40, p.102506, Article 102506

2022

Volltextzugriff (PDF)

Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response

Journal of controlled release, 2012-12, Vol.164 (3), p.331-337

2012

Volltextzugriff (PDF)

A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog

Journal of controlled release, 2012-06, Vol.160 (3), p.468-476

2012

Volltextzugriff (PDF)

Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[N-(N′,N′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome Retention Mediates Stronger Th1 Responses

Molecular pharmaceutics, 2011-02, Vol.8 (1), p.153-161

2011

Volltextzugriff (PDF)

Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis

Journal of drug targeting, 2011-09, Vol.19 (8), p.624-631

2011

Volltextzugriff (PDF)

Subunit Vaccines: Distearoylphosphatidylcholine-Based Liposomes Entrapping Antigen Offer a Neutral Alternative to Dimethyldioctadecylammonium-Based Cationic Liposomes as an Adjuvant Delivery System

Journal of pharmaceutical sciences, 2011-05, Vol.100 (5), p.1856-1865

2011

Volltextzugriff (PDF)

Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines

Vaccine, 2011-06, Vol.29 (29), p.4761-4770

2011

Volltextzugriff (PDF)

Liposome-mediated DNA vaccination: the effect of vesicle composition

Vaccine, 2001-04, Vol.19 (23-24), p.3301-3310

2001

Volltextzugriff (PDF)

A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice

Journal of pharmacy and pharmacology, 2006-06, Vol.58 (6), p.787-799

2006

Volltextzugriff (PDF)

Increased potential of a cationic liposome-based delivery system: Enhancing stability and sustained immunological activity in pre-clinical development

European journal of pharmaceutics and biopharmaceutics, 2010-11, Vol.76 (3), p.404-412

2010

Volltextzugriff (PDF)

Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen

Journal of controlled release, 2007-05, Vol.119 (1), p.102-110

2007

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Animals
(31)
Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Liposomes
(22)
Pharmacology & Pharmacy
(22)
Female
(21)
Biological And Medical Sciences
(16)
Mice, Inbred Balb C
(16)
Medical Sciences
(13)
Mice, Inbred C57bl
(13)
Adjuvant
(12)
Chemistry
(12)
General Pharmacology
(12)
Pharmaceutical Technology. Pharmaceutical Industry
(12)
Pharmacology. Drug Treatments
(12)
Adjuvants, Immunologic - Administration & Dosage
(11)
Chemistry, Multidisciplinary
(11)
Physical Sciences
(11)
Quaternary Ammonium Compounds - Chemistry
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response

Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems

Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation

Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses

The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production

Developing solid particulate vaccine adjuvants: surface bound antigen favours a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity

The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: The immunological consequences of the biodistribution profile

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency

Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen

Effect of Incorporating Cholesterol into DDA:TDB Liposomal Adjuvants on Bilayer Properties, Biodistribution, and Immune Responses

Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants

Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirus

Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response

A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog

Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[N-(N′,N′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome Retention Mediates Stronger Th1 Responses

Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis

Subunit Vaccines: Distearoylphosphatidylcholine-Based Liposomes Entrapping Antigen Offer a Neutral Alternative to Dimethyldioctadecylammonium-Based Cationic Liposomes as an Adjuvant Delivery System

Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines

Liposome-mediated DNA vaccination: the effect of vesicle composition

A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice

Increased potential of a cationic liposome-based delivery system: Enhancing stability and sustained immunological activity in pre-clinical development

Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen

Aktive Filter

Suchergebnisse filtern